Syngene International Ltd - 539268 - Board Meeting Outcome for Outcome Of The Board Meeting - July 20, 2022
Outcome of the Board Meeting - July 20, 202220-07-2022
20-07-2022
Syngene International Ltd - 539268 - Board Meeting Outcome for Outcome Of The Board Meeting - July 20, 2022
Outcome of the Board Meeting - July 20, 202220-07-2022
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the intimation for conference call for Analysts and Investors to be held on Thursday, July 21, 2022.18-07-2022
Deal with Zoetis could be worth $500 mn in 10 yrs: Syngene In'l chief
In a Q&A, Jonathan Hunt, MD & CEO of the Biocon arm, dwells on his firm's initiatives to overcome supply chain bottlenecks and other issues17-07-2022
Syngene International signs 10-year agreement with US-based firm Zoetis
Librela or bedinvetmab has already been launched in Europe and the UK, and has won 'Best new companion animal product' by IHS Markit Connect in 202115-07-2022
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed the press release titled 'Syngene signs 10-year biologics manufacturing agreement with leading animal health company, Zoetis'.14-07-2022
Syngene International Ltd - 539268 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Priyadarshini MahapatraDesignation :- Company Secretary and Compliance Officer12-07-2022
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Acquisition
In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has entered into an agreement for the purpose of acquisition of renewable power by acquiring equity stake up to 26% in Ampyr Renewable Energy Resources Eleven Private Limited ('AREREPL'), Special Purpose Vehicle formed by Ampyr India Asset Holdings Private Limited, for generation and supply of solar power.12-07-2022
Syngene International Ltd - 539268 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.07-07-2022
Syngene International Ltd - 539268 - Corrigendum To The Annual Report For FY 2021-22.
Corrigendum to the Annual Report for FY 2021-22.06-07-2022